Hepatitis C Community
new research
About This Community:

This forum is for questions about medical issues and research aspects of Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new Hepatitis Social/Living with Hepatitis forum

Font Size:
A
A
A
Background:
Blank
Blank
Blank
Blank
Blank Blank

new research

I am so happy to hear of any research for HCV that doesn't include interferon.
Thanks to mikesimon for letting me about this one.

(May 5, 2009 09:00 PM
Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). The new antibody effectively neutralized the virus in culture, and then prevented infection by the virus in a pre-clinical animal model of the disease.)

(August 6, 2009)

The University of Massachusetts Medical School's MassBiologics laboratory in Boston has begun the first phase of a clinical trial of a new Hepatitis C treatment.
The treatment is based on an antibody called MBL-HCV1. It will be given to 30 volunteers in escalating doses until the trial concludes later this year. A second phase will focus on liver transplant patients.

Hepatitis C attacks the liver and can lead to liver failure. The virus kills about 10,000 people annually and more than 3 million Americans are chronically infected with Hepatitis C.

The antibody developed by MassBiologics is designed to be used shortly before and after liver transplant surgery. Researchers also think it could be used in patients that are newly diagnosed with Hepatitis C.
MassBiologics is a nonprofit, licensed manufacturer of vaccines and other biologic products. The laboratory produces 30 percent of the United States' tetanus/diphtheria vaccine supply. It is run by UMass Medical School professor Donna Ambrosino.
Related Discussions
2 Comments Post a Comment
Blank
751342 tn?1297434382
Boy wouldn't that be nice if that one pans out. Most of my problems with sx were due to interferon.
Blank
Avatar f tn
This sounds very encouraging. Thank you for posting this.
Blank
Post a Comment
To
Recent Activity
3060903 tn?1398568723
Blank
Nighthawk61 I DO NOT KNOW THE WORD FEAR... Comment
9 hrs ago
408795 tn?1324939275
Blank
fretboard uploaded new photos
May 04
463897 tn?1448485050
Blank
MH Community Mgr commented on Bubulous's status
May 03
Blank
Weight Tracker
Track your weight over time
Start Tracking Now
Top Hepatitis Answerers
683231 tn?1438659664
Blank
Auburn, WA
317787 tn?1460223707
Blank
DC
163305 tn?1333672171
Blank
Rural Mural, CA
446474 tn?1446351282
Blank
San Francisco, CA
Avatar universal
Blank
1815939 tn?1377995399
Blank
Hepatitis C Community Resources
RSS Expert Activity
233488 tn?1310696703
Blank
Marathon Running Done Over Many Yea...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
233488 tn?1310696703
Blank
New Article on Multifocal IOL vs &q...
May 21 by John C Hagan III, MD, FACS, FAAOBlank
748543 tn?1443740527
Blank
TMJ/TMJ The Connection Between Teet...
01/15 by Hamidreza Nassery , DMD, FICOI, FAGD, FICCMOBlank
Top Hepatitis Answerers
683231 tn?1438659664
Blank
Auburn, WA
317787 tn?1460223707
Blank
DC
163305 tn?1333672171
Blank
Rural Mural, CA
446474 tn?1446351282
Blank
San Francisco, CA
Avatar universal
Blank
1815939 tn?1377995399
Blank